Search Results
Jun 16, 2026, 09:11 ET 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
Companies mentioned: Ventripoint Diagnostics Ltd. (TSXV: VPT) (OTCQB: VPTDF), HeartFlow, Inc. (Nasdaq: HTFL), Butterfly Network, Inc. (NYSE: BFLY), Tempus AI, Inc. (Nasdaq: TEM), iRhythm Technologies, Inc. (Nasdaq: IRTC)Into that gap steps a coordinated industry response — and a company
More news about: Equity Insider
May 19, 2026, 08:55 ET Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
past year — and the procurement environment for AI medtech is reshaping in real time as a result.Butterfly Network, Inc. (NYSE: BFLY) is one of the highest-profile names in handheld ultrasound. The Company has continued to expand integrations between its iQ family of probes and third-party
More news about: USA News Group
Mar 03, 2026, 12:19 ET Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes
alongside clinical accuracy[2]. Companies like VentriPoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF), Butterfly Network (NYSE: BFLY), Tempus AI (NASDAQ: TEM), RadNet (NASDAQ: RDNT), and GE HealthCare (NASDAQ: GEHC) are converting clinical validation into contracted
More news about: USA News Group
Jan 27, 2026, 10:14 ET AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market
treatments[4]. This high-stakes convergence positions VentriPoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF), Butterfly Network (NYSE: BFLY), RadNet (NASDAQ: RDNT), Nanox Imaging (NASDAQ: NNOX), and OneMedNet (NASDAQ: ONMD) as the essential engineering nodes where software-defined
More news about: USA News Group
Jan 16, 2026, 11:56 ET Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic
bridge" companies anchoring this new care model, including VentriPoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF), Butterfly Network (NYSE: BFLY), Hyperfine (NADSAQ: HYPR), Hologic (NASDAQ: HOLX), and GE HealthCare (NASDAQ: GEHC).
More news about: USA News Group
Oct 23, 2025, 08:30 ET Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market
in women with dense breast tissue. IzoView aligns with leading innovators such as NVIDIA Corp. (NASDAQ: NVDA), Butterfly Network Inc. (NYSE: BFLY), Lantheus Holdings Inc. (NASDAQ: LNTH), and RadNet Inc. (NASDAQ: RDNT), all of which are driving the integration of artificial intelligence
More news about: NetworkNewsWire